Abstract
The Wilm's tumor suppressor gene, wt1, is expressed in a very defined spatial-temporal fashion and plays a key role in development of the urogenital system. Trans-acting factors governing wt1 expression are poorly defined. The presence of putative κB binding sites within the wt1 gene prompted us to investigate whether members of the NF-κB/Rel family of transcription factors are involved in regulating wt1 expression. In transient transfection assays, ectopic expression of p50 and p65 subunits of NF-κB stimulated wt1 promoter activity 10–30-fold. Deletion mutagenesis revealed that NF-κB responsiveness is mediated by a short DNA fragment located within promoter proximal sequences of the major transcription start site. Two κB-binding sites are present in this region and form specific complexes with purified NF-κB proteins, as revealed by electrophoretic mobility gel shift assays. Ectopic expression of p50 and p65 resulted in increased transcription of the endogenous wt1 gene, as revealed by nuclear run-on experiments. Taken together, these results indicate that members of the NF-κB/Rel family are important for activating expression of wt1 and reside upstream of the regulatory cascade leading to wt1 activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dehbi, M., Hiscott, J. & Pelletier, J. Activation of the wt1 Wilms' tumor suppressor gene by NF-κB. Oncogene 16, 2033–2039 (1998). https://doi.org/10.1038/sj.onc.1201747
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201747
Keywords
This article is cited by
-
Upregulation of Wilms’ Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice
Cell Death & Differentiation (2022)
-
Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance
Cell Death & Differentiation (2022)
-
Wilms’ tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma
Journal of Gastroenterology (2013)
-
Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response
Cancer Immunology, Immunotherapy (2011)
-
Ouabain protects against adverse developmental programming of the kidney
Nature Communications (2010)